Isomorphic Labs Nears $2 Billion Funding Round Led by Thrive Capital with Alphabet Participation
Summary
Isomorphic Labs, the AI-driven drug discovery spinout from Google DeepMind, is closing in on a massive $2 billion funding round led by Thrive Capital, with Alphabet also joining the deal.
Key Points
- Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced discussions to raise more than $2 billion in a new funding round.
- Thrive Capital, which led Isomorphic Labs' first funding round last year, is set to lead the new financing round.
- Alphabet is also participating in the round, though the deal has not yet been officially closed.